Peak Bio, Inc. announced that it entered into a subscription agreement for private placement of 50,000 common shares at an issue price of $10 per share for gross proceeds of $500,000 on December 30, 2022. The company will also issue 46,500 warrants to purchase common shares, at an exercise price of $0.01 per share.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0096 USD | +11.63% |
|
+11.63% | -94.88% |
25/06 | Peak Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
28/05 | Peak Bio, Inc. announced that it has received $1.3245 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-94.88% | 222K | |
+19.41% | 45.51B | |
-8.62% | 38.52B | |
+38.20% | 38.13B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- PKBO Stock
- News Peak Bio, Inc.
- Peak Bio, Inc. announced that it expects to receive $0.5 million in funding